TORONTO, July 15, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company") is pleased to announce that its MRI-guided, AI-powered, Robotically-Driven and Incisionless TULSA Procedure™ will be highlighted in several presentations by leading physicians at the upcoming Society of Robotic Surgery ("SRS") Annual Meeting to be held in Fort Lauderdale, FL, July 23-26, 2026.*
MAIN CONGRESS SESSIONS
Real-world Outcomes after MRI-guided Transurethral Ultrasound Ablation of the Prostate in a Multicenter Post-market Registry
Xiaosong Meng, MD, PhD; UT Southwestern Medical Center, Dallas, TX
July 24, 2026; 9:55:10:00 a.m. EDT
CAPTAIN Randomized Controlled Trial of MRI-guided Transurethral Ultrasound Ablation (TULSA) vs. Radical Prostatectomy: Primary Safety Outcomes
Xiaosong Meng, MD, PhD; UT Southwestern Medical Center, Dallas, TX
July 24, 2026; 10:00-10:04 a.m. EDT
MRI-Guided Transurethral Ultrasound Ablation (TULSA) for Localized Prostate Cancer: Single-Center Efficacy and Safety Outcomes
Xiaosong Meng, MD, PhD; UT Southwestern Medical Center, Dallas, TX
July 24, 2026; 10:30-10:34 a.m. EDT
Intermediate Term Oncologic and Functional Outcomes of Incisionless Robotic Prostatectomy (Whole-Gland TULSA) for Extreme Apical Prostate Cancer
Victoria Y. Bird, MD; National Medical Association and Research Group, Gainesville, FL
July 24, 2026; 10:46-10:50 a.m. EDT
Salvage MRI-Guided Transurethral Ultrasound Ablation (TULSA) for Locally Recurrent Prostate Cancer Following Focal Therapy or Radiation: Oncologic and Functional Outcomes from a Single-Center Cohort
Victoria Y. Bird, MD; National Medical Association and Research Group, Gainesville, FL
July 24, 2026; 10:50-10:55 a.m. EDT
Building a Prostate Ablation Program - Lessons from Adopting TULSA at a High-Volume Academic Medical Center (Lunch Symposium)
Xiaosong Meng, MD, PhD; UT Southwestern Medical Center, Dallas, TX
July 24, 2026; 12:30-1:30 p.m. EDT
Robotic Assisted/AI Precision Prostate Cancer Treatment
Arun Menawat, PhD; Profound Medical
Masayoshi Miura, MD, PhD; Sapporo Hokuyu Hospital, Sapporo, Japan
July 26, 2026; 9:05-9:25 a.m. EDT
TULSA: Patient Selection and Outcomes (CAPTAIN Trial)
Xiaosong Meng, MD, PhD; UT Southwestern Medical Center, Dallas, TX
July 26, 2026; 1:25-1:45 p.m. EDT
Dr. Meng commented, "UT Southwestern has helped pioneer the TULSA Procedure for prostate cancer, having reached the 100th procedure milestone back in 2022, well before the CPT Category 1 codes became effective in January 2025. I am honored by this opportunity to share my experience, both as a surgeon and a researcher, at SRS2026."